Article Details
Retrieved on: 2025-03-16 22:41:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Sutro Biopharma (STRO) announced expanded data in a late-breaking oral presentation from the dose-optimization portion of the REFRalphaME-O1 trial ...
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here